Santa Clara, California-based Agilent Technologies, Inc. (A) provides application-focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. With a market cap of $41.6 billion, the company operates through Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab segments. The healthcare giant has slightly underperformed the broader market over the past year. Agilent’s stock prices have gained 9.3% on a YTD basis and 12.8% over the past 52 weeks, c ...